Real-life use of novel glucose lowering agents after acute myocardial infarction and stable coronary artery disease in patients with diabetes - experience from national use in the... von Ritsinger, V, Avander, K, Lagerqvist, B, Lundman, P, Norhammar, A

Volltext

Trends in prognosis and use of SGLT2i and GLP-1 RA in patients with diabetes and coronary artery disease von Ritsinger, Viveca, Avander, Kamila, Lagerqvist, Bo, Lundman, Pia, Norhammar, Anna

Volltext

Ambulatory fludrocortisone suppression test in the diagnosis of primary aldosteronism: Safety, accuracy and cost‐effectiveness von Carasel, Ana, Calissendorff, Jan, Avander, Kamila, Shabo, Ivan, Volpe, Cristina, Falhammar, Henrik

Volltext

Real-life use of novel glucose lowering agents in coronary artery disease: experience from the SWEDHEART-registry von Ritsinger, V, Avander, K, Lagerqvist, B, Lundman, P, Norhammar, A

Volltext

SplitTester: software to identify domains responsible for functional divergence in protein family von Gao, Xiang, Vander Velden, Kent A, Voytas, Daniel F, Gu, Xun

Volltext

PRINCIPLES OF DEVELOPMENT OF MODEL HEALTH CARE PROGRAMMES von Antonov, I. P., Aromaa, A., Avander, S., Axelsson, A., Closs, J. M., Drummond, M. F., Eckerlund, I., Isacsson, S.-O., Kokkola, K., Kulzhanov, M. H., Lindmark, C., Montell, R., Paatero, H., Pietila, J., Reerink, E., Vaissalo, T., Vuori, H., Wiedemann, E., Zöllner, H.

Volltext